arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Ascendis Pharma A/S

ASND Health Care Biotechnology: Pharmaceutical Preparations
$244.20
Today
as of Aug 5, 16:46 ET
Last 30 days -6.35% Jun 26 → Aug 05
$240.75 $250.53 $260.31 $270.10 $279.88 Jun 26 Jul 06 Jul 14 Jul 21 Jul 29 Aug 05
Open
$220.51
High
$222.55
Low
$209.56
Volume
$553,651
Avg Vol
$582,257
Mkt Cap
$15.1B
P/E (TTM)
—
Beta
—
52w High
$250.74
52w Low
$160.86
Div Yield
—
Shares Out
—

Recent Press Releases & News last 60 days · 16 items

Jul 24 · 15:03 Insider Monkey
Artisan Small Cap Fund Trimmed Ascendis Pharma (ASND) Amid Lawsuit Concerns
Jul 12 · 12:07 Simply Wall St.
Ascendis Pharma (ASND) Reports Two Year YUVIWEL Trial Data In Achondroplasia
Jul 12 · 06:11 Simply Wall St.
Ascendis Pharma (ASND) Stock Looks Above Fair Value As Shares Jump 24%
▸ Show all 16 press releases & news Free account →

Overview

52-week range
$161
$251
93% of range
Avg surprise (last 3)
+26.8%
Avg reaction (last 2)
+1.3%
50% positive
Latest IV / EM
62%
EM ±10.3% · $240 · Aug 21

Earnings trends

EPS — actual vs estimate Actual Estimate
$-1.66$-1.17$-0.67$-0.18$0.32 Actual $-1.66Est $-1.56Actual $-0.93Est $-1.42Actual $0.32Est $0.21 Mar/2025Jun/2025Mar/2026

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Thu May 7, 2026Mar/2026 $0.32 $0.21 +52.4% +119.3% +4.3% earnings
Thu Aug 7, 2025Jun/2025 $-0.93 $-1.42 +34.5% — — earnings
Thu May 1, 2025Mar/2025 $-1.66 $-1.56 -6.4% — -1.7% earnings

Upcoming

DateFiscalTimeEPS EstLY EPSYoY %Δ
Thu Aug 6, 2026Jun/2026OTHER $1.29-$0.93 +238.7%

Implied volatility — last 90 days

41%47%52%58%64% Jun 07 — IV 49% · EM ±6.8%Jun 08 — IV 47% · EM ±6.2%Jun 09 — IV 48% · EM ±6.0%Jun 10 — IV 44% · EM ±5.2%Jun 11 — IV 49% · EM ±5.4%Jun 12 — IV 42% · EM ±4.3%Jun 15 — IV 57% · EM ±4.1%Jun 16 — IV 52% · EM ±3.1%Jun 17 — IV 64% · EM ±2.7%Jun 19 — IV 42% · EM ±9.3%Jun 22 — IV 42% · EM ±8.7%Jun 23 — IV 50% · EM ±10.2%Jun 24 — IV 47% · EM ±9.4%Jun 25 — IV 54% · EM ±10.5%Jun 26 — IV 49% · EM ±9.3%Jun 29 — IV 46% · EM ±8.2%Jun 30 — IV 48% · EM ±8.3%Jul 01 — IV 44% · EM ±7.4%Jul 02 — IV 43% · EM ±6.9%Jul 03 — IV 44% · EM ±6.9%Jul 06 — IV 44% · EM ±6.1%Jul 07 — IV 45% · EM ±5.9%Jul 08 — IV 44% · EM ±5.6%Jul 09 — IV 46% · EM ±5.5%Jul 10 — IV 43% · EM ±4.8%Jul 13 — IV 56% · EM ±4.7%Jul 14 — IV 56% · EM ±4.0%Jul 15 — IV 54% · EM ±3.2%Jul 16 — IV 47% · EM ±2.0%Jul 20 — IV 51% · EM ±12.0%Jul 21 — IV 52% · EM ±12.1%Jul 22 — IV 51% · EM ±11.7%Jul 23 — IV 53% · EM ±11.8%Jul 24 — IV 52% · EM ±11.4%Jul 27 — IV 53% · EM ±11.1%Jul 28 — IV 54% · EM ±11.0%Jul 29 — IV 56% · EM ±11.2%Jul 30 — IV 55% · EM ±10.7%Jul 31 — IV 58% · EM ±11.0%Aug 03 — IV 58% · EM ±10.2%Aug 04 — IV 60% · EM ±10.3%Aug 05 — IV 62% · EM ±10.3%

Sector peers

LLY
Eli Lilly and Company
$1.1T $1,164.75-0.4%
JNJ
Johnson & Johnson
$624.1B $258.23+0.2%
ABBV
AbbVie Inc.
$454.8B $246.35+0.1%
MRK
Merck & Company, Inc.
$321.6B $129.20+0.7%
PM
Philip Morris International Inc
$299.3B $188.93-0.0%
NVS
Novartis AG
$297.9B $154.440.0%
View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in